Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of DHA-PQ vs ALu in Uncomplicated Malaria
NCT02590627Phase 4Completed
- Sponsor
- National Institute for Medical Research
- Start
- May 2014
- Primary completion
- Dec 2015
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by National Institute for Medical Research. Started May 2014; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02590627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590627.